Considering the differences between squamous cell carcinoma and adenocarcinoma, the underlying mechanism for the inhibitory effects of maspin on ESCC invasion may not be identical to that in carcinoma cells of breast and prostate origin. This evidence concerns the gene SERPINB5 and esophageal squamous cell carcinoma.